| Primary |
| Hypothyroidism |
53.3% |
| Growth Hormone Deficiency |
13.3% |
| Pseudohypoparathyroidism |
13.3% |
| Breast Cancer |
6.7% |
| Primary Hypothyroidism |
6.7% |
| Product Used For Unknown Indication |
6.7% |
|
| Product Quality Issue |
18.2% |
| Vomiting |
18.2% |
| Congenital Osteodystrophy |
9.1% |
| Dyspnoea |
9.1% |
| Hypertriglyceridaemia |
9.1% |
| No Therapeutic Response |
9.1% |
| Product Substitution Issue |
9.1% |
| Thyroid Function Test Abnormal |
9.1% |
| Vitamin D Deficiency |
9.1% |
|
| Secondary |
| Hypothyroidism |
17.1% |
| Product Used For Unknown Indication |
12.2% |
| Colorectal Cancer Metastatic |
9.8% |
| Chronic Hepatitis C |
7.3% |
| Chronic Obstructive Pulmonary Disease |
7.3% |
| Infection |
7.3% |
| Renal Transplant |
7.3% |
| Depression |
4.9% |
| Hypertension |
4.9% |
| Metastatic Gastric Cancer |
4.9% |
| Respiratory Depression |
4.9% |
| Rheumatoid Arthritis |
4.9% |
| Arthralgia |
2.4% |
| Familial Mediterranean Fever |
2.4% |
| Lipids Abnormal |
2.4% |
|
| Cervix Carcinoma |
7.1% |
| Inappropriate Antidiuretic Hormone Secretion |
7.1% |
| Post Cholecystectomy Syndrome |
7.1% |
| Posterior Reversible Encephalopathy Syndrome |
7.1% |
| Product Substitution Issue |
7.1% |
| Rhabdomyolysis |
7.1% |
| Salivary Hypersecretion |
7.1% |
| Skin Ulcer |
7.1% |
| Thrombocytopenia |
7.1% |
| Toxic Skin Eruption |
7.1% |
| Urinary Incontinence |
7.1% |
| Vasculitis Cerebral |
7.1% |
| Ventricular Extrasystoles |
7.1% |
| Vomiting |
7.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.2% |
| Hypertension |
9.2% |
| Drug Use For Unknown Indication |
9.1% |
| Hypothyroidism |
7.1% |
| Rheumatoid Arthritis |
7.1% |
| Asthma |
2.7% |
| Depression |
2.4% |
| Atrial Fibrillation |
2.3% |
| Pain |
2.2% |
| Crohn's Disease |
2.0% |
| Breast Cancer |
2.0% |
| Diabetes Mellitus |
2.0% |
| Osteoporosis |
1.8% |
| Breast Cancer Metastatic |
1.6% |
| Chronic Lymphocytic Leukaemia |
1.6% |
| Multiple Sclerosis |
1.6% |
| Hepatitis C |
1.6% |
| Prophylaxis |
1.6% |
| Thyroid Disorder |
1.5% |
| Psoriasis |
1.4% |
|
| Vomiting |
19.9% |
| Thrombocytopenia |
7.4% |
| Weight Decreased |
7.4% |
| Renal Failure Acute |
6.6% |
| Staphylococcal Infection |
5.9% |
| Rash |
5.1% |
| Pulmonary Embolism |
4.4% |
| Pyrexia |
4.4% |
| Tumour Lysis Syndrome |
4.4% |
| Syncope |
3.7% |
| Tremor |
3.7% |
| Urinary Tract Infection |
3.7% |
| Breast Cancer Female |
2.9% |
| Haemorrhage Urinary Tract |
2.9% |
| Oedema Peripheral |
2.9% |
| Off Label Use |
2.9% |
| Pruritus |
2.9% |
| Rheumatoid Arthritis |
2.9% |
| Sepsis |
2.9% |
| Skin Ulcer |
2.9% |
|
